Liaoning Accounts Payable from 2010 to 2024

688739 Stock   26.96  0.36  1.35%   
Liaoning Chengda's Accounts Payable is increasing over the years with slightly volatile fluctuation. Accounts Payable is expected to dwindle to about 146.5 M. Accounts Payable is the amount Liaoning Chengda Biotechnology owes to suppliers or vendors for products or services received but not yet paid for. It represents Liaoning Chengda's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
215.1 M
Current Value
146.5 M
Quarterly Volatility
40.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Liaoning Chengda financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Liaoning Chengda's main balance sheet or income statement drivers, such as Tax Provision of 102.7 M, Net Interest Income of 73.4 M or Interest Income of 75.4 M, as well as many indicators such as . Liaoning financial statements analysis is a perfect complement when working with Liaoning Chengda Valuation or Volatility modules.
  
This module can also supplement various Liaoning Chengda Technical models . Check out the analysis of Liaoning Chengda Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Liaoning Stock

Liaoning Chengda financial ratios help investors to determine whether Liaoning Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Liaoning with respect to the benefits of owning Liaoning Chengda security.